Patent holdings for IPC class A61K 31/445

Total number of patents in this class: 4508

10-year publication summary

274
275
270
246
283
275
271
226
272
201
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Amicus Therapeutics, Inc.
353
165
Merck Sharp & Dohme Corp.
2189
45
Takeda Pharmaceutical Company Limited
2713
39
Pacira Pharmaceuticals, Inc.
112
39
The Regents of the University of California
20211
38
Bristol-myers Squibb Company
4847
36
Janssen Pharmaceutica N.V.
3352
30
Merck Sharp & Dohme LLC
3739
30
Boehringer Ingelheim International GmbH
4649
28
ChemoCentryx, Inc.
378
28
Suven Life Sciences Limited
134
27
Novartis AG
10674
24
Centre National de La Recherche Scientifique
10641
22
Heron Therapeutics, Inc.
153
22
Theravance Biopharma R&D IP, LLC
454
21
H. Lundbeck A/S
1245
21
Corium, LLC
43
21
The Trustees of the University of Pennsylvania
4377
20
F. Hoffmann-La Roche AG
7944
19
The General Hospital Corporation
4794
19
Other owners 3814